Abstract
Purpose of Review
This article summarizes the current literature on the acute and outpatient assessment, management, and treatment of mild traumatic brain injury (mTBI).
Recent Findings
Emerging research indicates that there are different clinical profiles, or patterns of symptoms and deficits, that can occur due to mTBI. Advancements in assessment tools allows for improved detection of mTBI and delineation of the clinical profile after injury. Experts advocate for the development of an individualized treatment plan for specific symptoms and deficits from mTBI, rather than a “one-size-fits-all” approach to managing the injury.
Summary
This review provides a summary of the emerging literature for the evaluation and management of mTBI in the acute and outpatient settings.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Mild traumatic brain injury (mTBI), also known as concussion, is a growing public health concern [1, 2]. Nearly three million visits are made to the emergency department (ED) for traumatic brain injury (TBI) over the course of a year [3], and 70–90% of the TBIs treated in the hospital setting are classified as mild [4]. The most common causes of mTBIs are falls and motor vehicle accidents (MVAs) [4], but the prevalence of sport-related injuries seen in the trauma setting continues to rise. Between 1997 and 2007, the number of ED visits for sport-related mTBI more than doubled among children and adolescents [5]. Given the increased prevalence of mTBI in the trauma setting, it is important for frontline practitioners to be knowledgeable regarding this injury.
The scientific understanding and treatment of mTBI have evolved considerably over the past decade [6]. Improvements in the assessment tools for detecting and evaluating mTBI allow for better identification of the injury [7, 8] and for the development of an individualized treatment plan tailored to address the specific symptoms and deficits experienced by a patient. A “one-size-fits-all” approach to treatment or prescription of strict rest beyond the first 48 h of the injury is no longer considered the standard of care [6, 9•, 10•, 11, 12]. Emerging research indicates that there are different clinical profiles, or subtypes, that occur in mTBI [10•, 11, 12], and experts advocate for a targeted approach [13•] to treatment to address the different recovery patterns exhibited following the injury.
Injury Overview
Definition
The World Health Organization (WHO) defines mTBI as “an acute brain injury resulting from mechanical energy to the head from external physical forces” (pg 115) [14]. Table 1 lists the operational criteria for the diagnosis of the injury.
Blunt or blast trauma to the head and whiplash injuries that translate a traumatic force to the brain are encompassed within the definition of mTBI [2, 14]. Traditional markers of head injury (i.e., loss of consciousness (LOC), posttraumatic amnesia (PTA)) are not reliable predictors of severity of mTBI [15,16,17,18,19,20], and fewer than 20% of the mTBIs are accompanied by a LOC [16, 17]. Transient neurological abnormalities that may occur after injury include various physical (e.g., headache, seizure), sleep, cognitive, and emotional symptoms. Some of the most commonly reported symptoms are listed in Table 2.
Pathophysiology
Conventional neuroimaging (e.g., computed tomography [CT] scanning, magnetic resonance imaging [MRI]) for traumatic brain injury (TBI) is often unremarkable in patients with mTBI [21,22,23]. Patients with evidence of structural abnormalities on neuroimaging (e.g., subdural hematoma, contusion) and who meet criteria for mTBI are classified as having a complicated mTBI and exhibit a recovery pattern more similar to patients with a moderate TBI. In contrast, injuries with no evidence of a structural abnormality are classified as uncomplicated mTBIs [24, 25]. Patients with unremarkable imaging can still experience significant functional impairment and adverse symptomology from the neurometabolic crisis that occurs after this injury [22, 23, 26].
The traumatic force to the brain in mTBI results in the stretching and distortion of neuronal membranes that allows for indiscriminate ionic fluctuations disruptive to cell homeostasis. Restoration of this neurometabolic crisis requires a considerable amount of energy, and these physiological changes may render the brain more vulnerable to further cellular injury [22, 23]. An insult to the brain while in this metabolic crisis may have potentially catastrophic outcomes, such as in the case of second-impact syndrome (SIS). It is speculated that additional injury to the brain while in this vulnerable state can result in inflammation and cerebral edema that is rare, but can be fatal when it occurs [27, 28].
Recovery Time
Most mTBIs resolve within weeks to months of injury [6, 10•, 29, 30]. The recovery timeframe for mTBI is classified into three phases: acute (within 72 h post-injury), subacute (after 72 h to 3 months post-injury), and persistent/chronic (3 months and greater post-injury) [8]. Most adolescent athletes require 3–4 weeks to recover from a sport-related mTBI [10•, 31, 32]. Athletes experiencing symptoms beyond 4 weeks of injury are classified as having a prolonged or complicated recovery [6] and meet criteria for “Postconcussion Syndrome [33].” In comparison, the recovery time in adult mTBIs is typically 1 to 3 months, but some adults may experience symptoms for up to 12 months or longer [1, 30].
Emerging research has identified risk factors that predispose patients to exhibit a prolonged recovery from injury [11, 34]. Demographic characteristics including younger age [29, 35], female sex [35,36,37], and a history of prior mTBIs [34, 38, 39] have all been identified as risk factors for longer recovery time. Patients with certain preinjury health conditions may also be at risk for a complicated recovery after injury. One of the most robust predictors of postconcussion syndrome is a history of a mental health condition [4, 40,41,42]. Studies suggest that the preinjury mental health condition is more predictive of ongoing symptomology than the mTBI itself [40, 42]. Other health-related risk factors that may render individuals more vulnerable to mTBI include a history of migraine headaches [43, 44], neurodevelopmental conditions (e.g., attention deficit-hyperactivity disorder, learning disability) [45,46,47], and/or motion sickness [48]. It is speculated that preinjury neurological and psychological vulnerabilities may decompensate after sustaining a mTBI, resulting in an exacerbation of a preinjury condition and functional impairment [11, 41, 48].
The initial signs and symptoms evidenced within the acute phase of injury also provide important information on prognosis. As aforementioned, the presence of traditional markers of TBI (e.g., LOC or PTA) are not reliable predictors of recovery time from mTBI [15, 16, 18, 19, 49]. Recent research indicates that other reported symptoms or deficits may provide better insight into the underlying neural pathways disrupted by metabolic crisis. For instance, immediate reports of dizziness and mental fogginess are indicators of central vestibular dysfunction and predictive of prolonged recovery time [17, 20]; in sport-related injuries, athletes with positive findings on vestibular-oculomotor screening are expected to take longer to recover [48, 50], and these athletes may require physical therapy for rehabilitation of the vestibular system [51,52,53]. Additional symptom profiles that are associated with longer recovery time include the presence of posttraumatic migraine [54,55,56], mood changes/posttraumatic stress [57,58,59], sleep dysregulation [60,61,62], and oculomotor abnormalities [48, 63]. Each of these signs and symptoms reported after injury must be considered within a biopsychosocial context. For instance, involvement in litigation or the potential for secondary gain surrounding the injury is one of the strongest predictors of persistent disability from mTBI [1, 64]. Overall, there are several potential risk factors that may impact recovery time, and a consideration of these risk factors may help to identify patients at risk of a prolonged recovery.
Acute Evaluation
Detection
Immediate signs and symptoms that indicate a potential head injury has occurred are provided in Table 3. This list of indicators was developed by the medical personnel of the National Football League (NFL) [65] for assisting sports healthcare professionals in the identification of head injury from the sideline. Extensive protocols for detecting mTBI are critical in contact sports due to the risk of secondary insult and potentially catastrophic outcome if an athlete takes a blow to the head while actively concussed [27, 28]. Some clinical markers of head injury are apparent based purely on observation, while others require questioning or assessment of the individual [65]. The Centers for Disease Control and Prevention [66] recommends an evaluation in the ED if any emergent neurological signs or symptoms are present.
Emergent Neurological Disease
Ruling out emergent neurological sequelae is the first priority in considering a diagnosis of mTBI. The National Institutes of Health (NIH) recommends that the evaluation of TBI during acute hospitalization include a clinical interview, physical/neurological examination, imaging, functional assessments, and evaluation of vital signs, laboratory tests, and biomarkers. However, traditional neurodiagnostic testing is often unremarkable in uncomplicated mTBI [21,22,23]. Current guidelines recommend imaging be restricted to patients exhibiting high-risk neurological signs [26, 67] due to the radiation exposure [68], cost, and time [69] required for imaging. Researchers have developed protocols, such as the Canadian CT Head Rule, to empirically assist practitioners for deciding when to refer patients for a CT scan [26]. Once emergent neurological sequelae are dismissed, a diagnosis of mTBI may be considered.
Acute Assessment
Acute assessment of mTBI is largely based on a targeted clinical interview and functional assessment tools. Information gathered during the clinical interview includes details on the mechanism of injury, documentation of markers of injury/symptoms, and identification of potential risk factors for a complicated recovery. Table 4 provides an overview of a potential clinical interview.
Functional assessment tools are empirically established measures of skills and behaviors utilized in daily life. Performance on functional assessment tools has been shown to predict recovery and prognosis following mTBI [17, 50, 70]. It is recommended that a combination of both objective and subjective measures be included in the assessment [7, 8]. Standardized evaluation tools recommended by the NIH [7, 8] include neuropsychological testing, vestibular/oculomotor screening, and symptom report inventories (i.e., sleep quality, emotional functioning, TBI-related symptoms, quality of life). Scores on these measures can assist in determining diagnosis and prognosis [70,71,72,73], as well as establish the clinical profile from the injury, functional deficits, and appropriate treatment.
Acute Treatment
Recommending strict rest (i.e., no cognitive or physical activity) beyond 24 to 48 h of injury is no longer considered an acceptable treatment for mTBI [6]. Results of a randomized controlled trial indicate that adolescents diagnosed with mTBI in the ED who were advised to engage in strict rest rather than usual care (i.e., gradual return to activity after 48 h) reported a greater severity and longer duration of postconcussion symptoms [9•]. The advantage of an activity-based rather than rest-based model during acute recovery is likely related to the benefit of activity on neuroplasticity and the physiological adaptive responses that occur shortly after neuronal injury [74]. A modified schedule of activity and maintenance of healthy lifestyle factors (e.g., hydration, adequate nutrition, routine sleep schedule, stress management, low risk/light physical activity) in the acute phase of injury may assist in the mitigation of symptoms such as headache and sleep disruption and promote recovery [75,76,77]. Every acute evaluation should include education and normalization of expected symptoms after mTBI, as well as referral to a specialist for outpatient management of the injury [78, 79].
Outpatient Evaluation
The primary advantage of specialty evaluation and management of mTBI in the outpatient setting is the development of an individualized treatment plan. Through comprehensive, multimodal assessment and follow-up care, the symptom pattern, also referred to as the clinical profile, and potential functional impairments that ensue after injury can be identified and appropriately treated. Emerging clinical profiles include posttraumatic migraine, vestibular, oculomotor, anxiety/mood, and cognitive fatigue [11]. Each of these profiles requires different types of treatment. Expert consensus across multiple health disciplines (e.g., neuropsychology, neurosurgery, neurology, physical medicine and rehabilitation, physical therapy) advocates for an active, patient-centered treatment plan to benefit the recovery of patients, rather than a one-size-fits-all approach to treating this injury [13]. To develop an individualized treatment plan, the outpatient evaluation should include a clinical interview, functional assessment tools, and identification of the clinical profile.
Clinical Interview
Table 4 provides the general outline for information obtained as part of every clinical interview. In the outpatient setting, it is also important to establish any treatments that were already attempted, results of imaging and/or laboratory tests, nature and trajectory of symptoms, and current functional activities that are limited or affected by the injury. All information obtained in the clinical interview should be verified with medical records when possible. Given the multitude of risk factors associated with a prolonged recovery from this injury, reported symptoms and deficits must be considered within a biopsychosocial context. This includes focusing on risk factors in the medical or mental health history, injury characteristics, and psychosocial/environmental circumstances that put the patient at risk for a complicated recovery. Subjective information gleaned from the clinical interview should be compared to objective assessments when possible.
Functional Assessment Tools
Traditional neurodiagnostic testing is often not sensitive to the neurometabolic disruption that occurs after mTBI, and therefore, the outpatient evaluation of the injury is primarily conducted with empirically established functional assessment tools [7, 8]. International guidelines recommend that a comprehensive evaluation includes both objective and subjective measures of function [6]. Assessment tools must have the capability of being serially administered and provide reliable change indices to track whether meaningful recovery has occurred between time points. Standard evaluation of mTBI based on NIH guidelines [7, 8] includes the following assessment modalities: neurocognitive testing, symptom inventories, and vestibular/oculomotor screening. Table 5 provides a brief description of the specific types of testing included within each of these assessment modalities.
Neurocognitive Testing
Neurocognitive testing provides information on cognition to predict functional impairment. Aspects of cognition that are included within batteries for mTBI include measures of attention, learning, memory, language, visual spatial skills, fine motor skills, executive functioning, and intelligence/premorbid estimation [7, 8]. Results of neurocognitive testing are often interpreted by a neuropsychologist trained in conceptualizing cognitive patterns [80]. These patterns of impairment can be linked to specific neural networks affected by mTBI [81] and provide insight into a patient’s ability to function in the school or occupational setting. Computerized neurocognitive testing has become a widely utilized tool for measuring outcome after mTBI [6, 82], because it provides an objective measurement and because of its feasibility of use [83,84,85,86]. Patients who are reportedly symptom free may still demonstrate deficits on cognitive testing [86,87,88,89]. Performance on neurocognitive testing within the first 7–14 days of injury improves the ability to predict whether a patient will have a simple or complicated recovery [49, 72]. Effort and symptom validity testing are particularly important in situations in which there may be secondary gain associated with the injury [90, 91].
Symptom Inventories
Symptom inventories provide a method of quantitatively capturing the nature and severity of symptoms and functional impairments experienced by the patient. Endorsement of a high symptom burden in the acute phase of injury is a robust predictor of prolonged recovery from the injury [49, 70, 92]. Given that mTBI can result in a constellation of physical, cognitive, sleep, and mood symptoms, it is important to have a comprehensive understanding of the symptoms that are most bothersome to the patient. The pattern of symptoms endorsed can provide valuable information into the clinical profile of the injury [10•, 11, 12, 56].
Vestibular and Oculomotor Screening
The vestibular system is a complex sensory system that allows for central maintenance of balance and the stabilization of vision with movement. Patients with central vestibular problems after mTBI often report symptoms that are consistent with the sensation of motion sickness (e.g., dizziness, vertigo, lightheadedness, unstable vision, nausea, imbalance) [52, 73, 93,94,95]. Two aspects of the vestibular system that warrant screening after suspected head injury include testing of balance/postural stability and vestibular-oculomotor function. Balance testing is more useful in the acute phase of injury as balance problems appear to resolve within the first 72 h of injury [96, 97], while a positive finding on vestibular-ocular motor screening in the acute phase of injury is predictive of prolonged recovery time [50, 52, 73, 93].
Screening for oculomotor impairment after mTBI is also recommended as part of the neuromotor exam. The oculomotor system coordinates eye movements to focus vision. Between 24 and 48% of the patients evaluated within 1 month of injury will demonstrate posttraumatic oculomotor abnormalities [63, 71, 98], and these patients exhibit a prolonged recovery from the injury [48]. Patients with oculomotor dysfunction may experience difficulties in environments or with activities that involve a heavy demand on the visual system (e.g., reading in school, working on a computer screen).
Clinical Profiles
Information obtained through the clinical interview and standardized evaluation allows for the conceptualization of the clinical profile of this injury. Emerging research indicates that different clinical profiles and patterns of symptoms can occur after mTBI, and each profile warrants different types of treatment. These profiles are not considered mutually exclusive in that an individual can experience overlapping symptoms from multiple profiles. Identified clinical profiles include posttraumatic migraine, vestibular, oculomotor, anxiety/mood, and cognitive fatigue. The description of each of these clinical profiles provides a theoretical framework for conceptualizing and recognizing the nuanced differences in outcomes from mTBI [10•, 11, 12]. Individuals with preinjury vulnerabilities may be more at risk for the development of certain clinical profiles (e.g., a patient with a preinjury history of migraines develops a posttraumatic migraine secondary to the mTBI) [11, 41, 48]. The research on these clinical profiles is in its infancy, but preliminary findings support the notion that certain preinjury characteristics increase the risk of posttraumatic complications from mTBI, and specific deficits after mTBI necessitate targeted treatments [51, 52, 93]. The literature on mTBI continues to evolve, and further delineation of methods for identifying, evaluating, and treating these clinical profiles is warranted.
Posttraumatic Migraine
Headache is one of the most commonly reported symptoms after mTBI [99] and is classified as a posttraumatic migraine when the headache occurs within a week after the head trauma and is accompanied by symptoms of nausea and/or photophobia and phonophobia [100]. Migraine headaches are typically moderate or severe in intensity, have a pulsating quality, last for hours, and are aggravated by activity. Potential risk factors for this profile include a personal or family history of migraine [101]. Symptom inventories and questioning during the interview can help to determine if headaches are accompanied by nausea, photophobia, or phonophobia. Computerized test results may show a pattern of worsened verbal and visual memory scores [54]. Individuals demonstrating this profile are at risk for a prolonged recovery from mTBI [54,55,56] and may have difficulty tolerating daily functional activities. Treatment for this clinical profile may include employment of behavioral regulation strategies (i.e., regulated sleep, hydration, healthy diet, stress management, and cardiovascular exercise) [11, 75, 76], nutritional supplements for migraine headache [102,103,104], and in protracted cases pharmacological intervention [105].
Vestibular
Disturbance of the central vestibular system after head trauma typically results in the sensation of motion sickness [17]. Patients may report dizziness, fogginess, nausea, lightheadedness, and feeling overwhelmed in busy or complex environments [11]. The central vestibular system coordinates neural signals for maintaining postural stability and gaze stabilization and assists in making internal estimates of motion and spatial orientation [94]. Patients with a vestibular problem may be reportedly asymptomatic at rest until initiating movement or when involved in activities involving motion (e.g., car rides, crowded environments). A potential risk factor for the development of this profile after head injury includes a preinjury history of motion sickness, such as carsickness [48]. Symptom inventories can help to detect vestibular symptoms, but a vestibular-oculomotor screening is warranted for capturing such abnormalities. Patients with this profile often experience the onset or worsening of motion sickness symptoms when engaged in exams of oculomotor function, vestibular-ocular reflexes, and visual motion sensitivity [12, 50, 73]. Treatment often requires rehabilitation of the vestibular system through a structured physical therapy plan [51,52,53, 93, 106], and in protracted cases that involve autonomic nervous system changes, pharmacological interventions may be warranted [107].
Oculomotor
Posttraumatic vision changes from central disturbance of oculomotor control are common after TBI [71, 108]. The most common oculomotor abnormalities following a mTBI affect accommodation and convergence functions that maintain near vision [108, 109]. Symptoms that may serve as an indicator of an oculomotor deficit include reported trouble focusing eyes, blurred/double vision, frontal-based headache and/or head pressure, or fatigue/discomfort with activities with a heavy visual demand (e.g., reading, computer work) [11, 71, 110]. Oculomotor deficits can be captured by neuromotor screening tools (i.e., examination of smooth pursuits, saccades, near point of convergence, and accommodation) [73, 111,112,113], evaluation by a neuro-optometrist [48], or detection of a pattern of lowered performance on computerized testing [63, 71]. Further research is warranted to determine if developmental oculomotor abnormalities, such as strabismus, are associated with posttraumatic vision changes after mTBI. Oculomotor abnormalities can lead to occupational and school impairments, especially if responsibilities require prolonged use of near vision [11, 63, 114]. Recent research indicates that oculomotor abnormalities may increase the recovery time from mTBI among children [48, 50]. Treatment options may include vestibular-ocular therapy, vision therapy, and/or eyeglasses [12, 115].
Anxiety/Mood
Mood changes and emotional disturbances can occur after head trauma. Physiological alterations in limbic-cortical circuitry and neurotransmitter release from the neurometabolic crisis that ensues after mTBI resemble that of major depression and other mood disturbances [22, 23, 116, 117]. Symptoms that are indicative of emotional problems include ruminative thinking, sadness, emotional lability, difficulties initiating and maintaining sleep, panic attacks, nervousness, and hypervigilance. These individuals may demonstrate avoidant behaviors (e.g., wearing sunglasses indoors, dimming brightness on computer screens, wearing noise-canceling headphones) when attempting to return to functional activities [118,119,120,121]. Assessment of the anxiety/mood clinical profile largely resides on a thorough clinical interview, the use of symptom inventories, and a comparison of objective data to subjective symptom complaints. Inconsistencies in reported symptoms (e.g., memory problems) and performance on objective testing (e.g., neuropsychological measures of memory function) can assist in determining whether physical complaints have a psychological basis [11, 122]. A preinjury history of mental health problems is a risk factor for developing this profile and is one of the strongest predictors of postconcussion syndrome [1, 40, 42]. Treatments that have been recommended for this profile [122] in the initial phases include psychoeducation [78, 123] and a gradual return to functional activities [11, 94, 124, 125], while more protracted cases may require psychotherapy [126,127,128] and/or pharmacological interventions [129, 130].
Cognitive Fatigue
Patients presenting with predominant complaints of cognitive difficulties (e.g., memory and attention problems) and fatigue are characterized as exhibiting a cognitive fatigue profile. Neurocognitive testing provides an objective measure of cognitive processes to elucidate this profile [11]. Further research is warranted to determine the risk factors and trajectory of recovery from this profile. Potential treatment options in protracted cases include cognitive rehabilitation [123] and pharmacological intervention [131].
Return to Functional Activities
There are several considerations that must be made prior to returning a patient with mTBI to his or her usual daily activities. The first consideration is the safety of the patient. Any activities that pose a risk of head injury are strongly discouraged given the risk of catastrophic outcome with a second insult to the head [27, 28]. For instance, in order to return an athlete to a contact sport, international criteria require that the athlete is symptom free at rest, symptom free with non-contact physical activity, and demonstrates a normal exam [6]. Occupational hazards and involvement in high-risk tasks (e.g., balance on scaffolding, operating heavy machinery, or financial investing) are also a safety concern and must be considered within the context of the assessment results and clinical profile to ensure no harm is done to the patient or others.
Another major consideration is the patient’s ability to be productive and tolerate the occupational or school environment. Recommending strict rest beyond a period of 48 h postinjury is ill advised, and instead, light activity or a modified schedule may be more beneficial for recovery [9•, 74, 77, 132]. This allows the patient to gradually increase his or her tolerance of daily activities. It is not unusual for patients to experience an initial spike in symptoms when first returning to functional activities such as the school environment, and this spike in symptoms does not appear to be detrimental to recovery [133]. The use of an “exposure-recovery model,” in which a patient engages in a symptom-provoking activity (exposure), and then takes a break or relaxes to allow symptoms to abate (recovery), may help to facilitate the return to activity. This model has been demonstrated to be effective in affective disorders and may particularly benefit patients at risk for mood disturbances [134, 135]. Specialty management of the injury utilizes the individualized clinical profile to determine tolerance and to guide the return to functional activities.
Conclusion
Advances in the scientific understanding of and assessment tools for mTBI have led to improvements in the evaluation, management, and treatment of this injury. Emerging research indicates that certain risk factors and clinical profiles after injury may predispose patients to experience different recovery patterns. Prescription of strict rest beyond the acute phase of injury and a “one-size-fits all” approach are no longer recommended as the standard of care. Experts advocate for an individualized treatment plan to address the specific symptoms and deficits exhibited after injury.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Carroll LJ, Cassidy JD, Peloso PM, Borg J, von Holst H, Holm L, et al. Prognosis for mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury. J Rehabil Med. 2004;36(0):84–105.
Prevention C. f. D. C. a. 2017 November 9, 2017. Traumatic brain injury & concussion. https://www.cdc.gov/traumaticbraininjury/index.html. Accessed 9 Nov 2017.
Taylor CA. Traumatic brain injury-related emergency department visits, hospitalizations, and deaths—United States, 2007 and 2013. MMWR Surveill Summ. 2017;66:1–16.
Cassidy JD, Carroll L, Peloso P, Borg J, Von Holst H, Holm L, et al. Incidence, risk factors and prevention of mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury. J Rehabil Med. 2004;36(0):28–60.
Bakhos LL, Lockhart GR, Myers R, Linakis JG. Emergency department visits for concussion in young child athletes. Pediatrics. 2010;126(3):e550–6.
McCrory P, Meeuwisse W, Dvorak J, Aubry M, Bailes J, Broglio S, et al. Consensus statement on concussion in sport—the 5th international conference on concussion in sport held in Berlin, October 2016. Br J Sports Med. 2017; https://doi.org/10.1136/bjsports-2017-097699.
National Institute of Neurological Disorders and Stroke 2017. February16, 2017.Traumatic Brain Injury. https://wwwcommondataelementsnindsnihgov/TBIaspx#tab=Data_Standards. Feb 16 2017.
National Institute of Neurological Disorders and Stroke 2017. March 27, 2017. Sport-related concussion common data elements. https://www.commondataelements.ninds.nih.gov/SRC.aspx#tab=Data_Standards. Accessed 27 March 2017.
• Thomas DG, Apps JN, Hoffmann RG, McCrea M, Hammeke T. Benefits of strict rest after acute concussion: a randomized controlled trial. Pediatrics. 2015;135(2):21-223This randomized controlled trial demonstrates the deleterious effects that prolonged rest can have on a patient with a mTBI.
• Henry LC, Elbin RJ, Collins MW, Marchetti G, Kontos AP. Examining recovery trajectories after sport-related concussion with a multimodal clinical assessment approach. Neurosurgery. 2016;78(2):232–41. This reference demonstrates the heterogeneity in recovery after concussion, and the importance of utilizing the appropriate assessment tools for evaluation.
Collins MW, Kontos AP, Reynolds E, Murawski CD, Fu FH. A comprehensive, targeted approach to the clinical care of athletes following sport-related concussion. Knee Surg Sports Traumatol Arthrosc: Off J ESSKA. 2014;22(2):235–46.
Ellis MJ, Leddy JJ, Willer B. Physiological, vestibulo-ocular and cervicogenic post-concussion disorders: an evidence-based classification system with directions for treatment. Brain Inj. 2015;29(2):238–48.
• Collins MW, Kontos AP, Okonkwo DO, Almquist J, Bailes J, Barisa M, et al. Statements of agreement from the targeted evaluation and active management (TEAM) approaches to treating concussion meeting held in Pittsburgh, October 15–16, 2015. Neurosurgery. 2016;79(6):912–29. This reference highlights experts’ opinion and the general trend in the field towards viewing concussion as an individualized injury that is treatable.
MTBIC. Methodological issues and research recommendations for mild traumatic brain injury: the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury. J Rehabil Med. 2004;43:113–25.
Lovell MR, Iverson GL, Collins MW, McKeag D, Maroon JC. Does loss of consciousness predict neuropsychological decrements after concussion? Clin J Sport Med: Off J Can Acad Sport Med. 1999;9(4):193–8.
Collins MW, Iverson GL, Lovell MR, McKeag DB, Norwig J, Maroon J. On-field predictors of neuropsychological and symptom deficit following sports-related concussion. Clin J Sport Med: Off J Can Acad Sport Med. 2003;13(4):222–9.
Lau BC, Kontos AP, Collins MW, Mucha A, Lovell MR. Which on-field signs/symptoms predict protracted recovery from sport-related concussion among high school football players? Am J Sports Med. 2011;39(11):2311–8.
McCrea M, Guskiewicz K, Randolph C, Barr WB, Hammeke TA, Marshall SW, et al. Incidence, clinical course, and predictors of prolonged recovery time following sport-related concussion in high school and college athletes. J Int Neuropsychol Soc. 2013;19(1):22–33.
Meehan WP 3rd, Mannix RC, Stracciolini A, Elbin RJ, Collins MW. Symptom severity predicts prolonged recovery after sport-related concussion, but age and amnesia do not. J Pediatr. 2013;163:721–5.
Zemek RL, Farion KJ, Sampson M, McGahern C. Prognosticators of persistent symptoms following pediatric concussion: a systematic review. JAMA Pediatr. 2013;167(3):259–65.
Sadowski-Cron C, Schneider J, Senn P, Radanov BP, Ballinari P, Zimmermann H. Patients with mild traumatic brain injury: immediate and long-term outcome compared to intra-cranial injuries on CT scan. Brain Inj. 2006;20(11):1131–7.
Barkhoudarian G, Hovda DA, Giza CC. The molecular pathophysiology of concussive brain injury. Clin Sports Med. 2011;30(1):33–48. vii-iii
Giza CC, Hovda DA. The neurometabolic cascade of concussion. J Athl Train. 2001;36(3):228–35.
Iverson GL. Complicated vs uncomplicated mild traumatic brain injury: acute neuropsychological outcome. Brain Inj. 2006;20(13–14):1335–44.
Temkin NR, Machamer JE, Dikmen SS. Correlates of functional status 3–5 years after traumatic brain injury with CT abnormalities. J Neurotrauma. 2003;20(3):229–41.
Stiell IG, Wells GA, Vandemheen K, Clement C, Lesiuk H, Laupacis A, et al. The Canadian CT Head Rule for patients with minor head injury. Lancet. 2001;357(9266):1391–6.
Cantu RC, Gean AD. Second-impact syndrome and a small subdural hematoma: an uncommon catastrophic result of repetitive head injury with a characteristic imaging appearance. J Neurotrauma. 2010;27(9):1557–64.
McCrory P, Davis G, Makdissi M. Second impact syndrome or cerebral swelling after sporting head injury. Curr Sports Med Rep. 2012;11(1):21–3.
Williams RM, Puetz TW, Giza CC, Broglio SP. Concussion recovery time among high school and collegiate athletes: a systematic review and meta-analysis. Sports Med. 2015;45(6):893–903.
Ponsford J, Willmott C, Rothwell A, Cameron P, Kelly A-M, Nelms R, et al. Factors influencing outcome following mild traumatic brain injury in adults. J Int Neuropsychol Soc. 2000;6(5):568–79.
McCrea M, Guskiewicz KM, Marshall SW, Barr W, Randolph C, Cantu RC, et al. Acute effects and recovery time following concussion in collegiate football players: the NCAA Concussion Study. JAMA. 2003;290(19):2556–63.
Iverson GL, Brooks BL, Collins MW, Lovell MR. Tracking neuropsychological recovery following concussion in sport. Brain Inj. 2006;20(3):245–52.
World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. 1992.
Abrahams S, Fie SM, Patricios J, Posthumus M, September AV. Risk factors for sports concussion: an evidence-based systematic review. Br J Sports Med. 2013; https://doi.org/10.1136/bjsports-2013-092734.
Covassin T, Elbin RJ, Harris W, Parker T, Kontos A. The role of age and sex in symptoms, neurocognitive performance, and postural stability in athletes after concussion. Am J Sports Med. 2012;40(6):1303–12.
Broshek DK, Kaushik T, Freeman JR, Erlanger D, Webbe F, Barth JT. Sex differences in outcome following sports-related concussion. J Neurosurg. 2005;102(5):856–63.
Colvin AC, Mullen J, Lovell MR, West RV, Collins MW, Groh M. The role of concussion history and gender in recovery from soccer-related concussion. Am J Sports Med. 2009;37(9):1699–704.
Guskiewicz KM, McCrea M, Marshall SW, Cantu RC, Randolph C, Barr W, et al. Cumulative effects associated with recurrent concussion in collegiate football players: the NCAA Concussion Study. JAMA. 2003;290(19):2549–55.
Teel EF, Marshall SW, Shankar V, McCrea M, Guskiewicz KM. Predicting recovery patterns after sport-related concussion. J Athl Train. 2017;52(3):288–98.
Ponsford J, Cameron P, Fitzgerald M, Grant M, Mikocka-Walus A, Schonberger M. Predictors of postconcussive symptoms 3 months after mild traumatic brain injury. Neuropsychology. 2012;26(3):304–13.
Silverberg ND, Iverson GL. Etiology of the post-concussion syndrome: physiogenesis and psychogenesis revisited. NeuroRehabilitation. 2011;29(4):317–29.
Meares S, Shores EA, Taylor AJ, Batchelor J, Bryant RA, Baguley IJ, et al. Mild traumatic brain injury does not predict acute postconcussion syndrome. J Neurol Neurosurg Psychiatry. 2008;79(3):300–6.
Gordon K, Dooley J, Wood E. Is migraine a risk factor for the development of concussion? Br J Sports Med. 2006;40(2):184–5.
Eckner JT, Seifert T, Pescovitz A, Zeiger M, Kutcher JS. Is migraine headache associated with concussion in athletes? A case–control study. Clin J Sport Med. 2017;27(3):266–70.
Iverson G, Wojtowicz M, Brooks BL, Maxwell BA, Atkins JE, Zafonte R, et al. High school athletes with attention deficit hyperactivity disorder and learning difficulties have a greater lifetime concussion history. J Atten Disord. 2016. https://doi.org/10.1177/1087054716657410.
Alosco ML, Fedor AF, Gunstad J. Attention deficit hyperactivity disorder as a risk factor for concussions in NCAA division-I athletes. Brain Inj. 2014;28(4):472–4.
Nelson LD, Guskiewicz KM, Marshall SW, Hammeke T, Barr W, Randolph C, et al. Multiple self-reported concussions are more prevalent in athletes with ADHD and learning disability. Clin J Sport Med. 2016;26(2):120–7.
Master CL, Master SR, Wiebe DJ, Storey EP, Lockyer JE, Podolak OE, et al. Vision and vestibular system dysfunction predicts prolonged concussion recovery in children. Clin J Sport Med. 2017. https://doi.org/10.1097/JSM.0000000000000507.
Lau BC, Collins MW, Lovell MR. Cutoff scores in neurocognitive testing and symptom clusters that predict protracted recovery from concussions in high school athletes. Neurosurgery. 2012;70(2):371–9; discussion 379.
Anzalone AJ, Blueitt D, Case T, McGuffin T, Pollard K, Garrison JC, et al. A positive vestibular/ocular motor screening (VOMS) is associated with increased recovery time after sports-related concussion in youth and adolescent athletes. Am J Sports Med. 2017;45(2);474–79.
Aligene K, Lin E. Vestibular and balance treatment of the concussed athlete. NeuroRehabilitation. 2013;32(3):543–53.
Alsalaheen BA, Mucha A, Morris LO, Whitney SL, Furman JM, Camiolo-Reddy CE, et al. Vestibular rehabilitation for dizziness and balance disorders after concussion. J Neurol Phys Ther. 2010;34(2):87–93.
Gurley JM, Hujsak BD, Kelly JL. Vestibular rehabilitation following mild traumatic brain injury. NeuroRehabilitation. 2013;32(3):519–28.
Kontos AP, Elbin RJ, Lau B, Simensky S, Freund B, French J, et al. Posttraumatic migraine as a predictor of recovery and cognitive impairment after sport-related concussion. Am J Sports Med. 2013;41:1497–504.
Mihalik JP, Register-Mihalik J, Kerr ZY, Marshall SW, McCrea MC, Guskiewicz KM. Recovery of posttraumatic migraine characteristics in patients after mild traumatic brain injury. Am J Sports Med. 2013;41:1490–6.
Mihalik JP, Stump JE, Collins MW, Lovell MR, Field M, Maroon JC. Posttraumatic migraine characteristics in athletes following sports-related concussion. J Neurosurg. 2005;102(5):850–5.
Brenner LA, Ivins BJ, Schwab K, Warden D, Nelson LA, Jaffee M, et al. Traumatic brain injury, posttraumatic stress disorder, and postconcussive symptom reporting among troops returning from Iraq. J Head Trauma Rehabil. 2010;25(5):307–12.
Bryant RA, Creamer M, O’donnell M, Silove D, Clark CR, McFarlane AC. Post-traumatic amnesia and the nature of post-traumatic stress disorder after mild traumatic brain injury. J Int Neuropsychol Soc. 2009;15(6):862–7.
Pietrzak RH, Johnson DC, Goldstein MB, Malley JC, Southwick SM. Posttraumatic stress disorder mediates the relationship between mild traumatic brain injury and health and psychosocial functioning in veterans of Operations Enduring Freedom and Iraqi Freedom. J Nerv Ment Dis. 2009;197(10):748–53.
Kostyun RO, Milewski MD, Hafeez I. Sleep disturbance and neurocognitive function during the recovery from a sport-related concussion in adolescents. Am J Sports Med. 2014; https://doi.org/10.1177/0363546514560727.
Bramley H, Henson A, Lewis MM, Kong L, Stetter C, Silvis M. Sleep disturbance following concussion is a risk factor for a prolonged recovery. Clin Pediatr. 2016; https://doi.org/10.1177/0009922816681603.
Schreiber S, Barkai G, Gur-Hartman T, Peles E, Tov N, Dolberg OT, et al. Long-lasting sleep patterns of adult patients with minor traumatic brain injury (mTBI) and non-mTBI subjects. Sleep Med. 2008;9(5):481–7.
Master CL, Scheiman M, Gallaway M, Goodman A, Robinson RL, Master SR, et al. Vision diagnoses are common after concussion in adolescents. Clin Pediatr. 2016;55(3):260–7.
Reynolds S, Paniak C, Toller-Lobe G, Nagy J. A longitudinal study of compensation-seeking and return to work in a treated mild traumatic brain injury sample. J Head Trauma Rehabil. 2003;18(2):139–47.
NFL Head Neck and Spine Committee. NFL Head, Neck, and Spine Committee’s Protocols Regarding Diagnosis and Management of Concussion. 2014.
Prevention C. f. D. C. a 2017. November 9, 2017. What are the signs and symptoms of concussion? https://www.cdc.gov/traumaticbraininjury/symptoms.html. Accessed 9 Nov 2017.
Sharif-Alhoseini M, Khodadadi H, Chardoli M, Rahimi-Movaghar V. Indications for brain computed tomography scan after minor head injury. J Emerg Trauma Shock. 2011;4(4):472.
Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380(9840):499–505.
Melnick ER, Szlezak CM, Bentley SK, Dziura JD, Kotlyar S, Post LA. CT overuse for mild traumatic brain injury. Jt Comm J Qual Patient Saf. 2012;38(11):483–9.
Lau B, Lovell MR, Collins MW, Pardini J. Neurocognitive and symptom predictors of recovery in high school athletes. Clin J Sport Med: Off J Can Acad Sport Med. 2009;19(3):216–21.
Pearce KL, Sufrinko A, Lau BC, Henry L, Collins MW, Kontos AP. Near point of convergence after a sport-related concussion: measurement reliability and relationship to neurocognitive impairment and symptoms. Am J Sports Med. 2015;43(12):3055–61.
Lau BC, Collins MW, Lovell MR. Sensitivity and specificity of subacute computerized neurocognitive testing and symptom evaluation in predicting outcomes after sports-related concussion. Am J Sports Med. 2011;39(6):1209–16.
Mucha A, Collins MW, Elbin RJ, Furman JM, Troutman-Enseki C, DeWolf RM, et al. A brief vestibular/ocular motor screening (VOMS) assessment to evaluate concussions: preliminary findings. Am J Sports Med. 2014;42(10):2479–86.
Nudo RJ. Recovery after brain injury: mechanisms and principles. Front Hum Neurosci. 2013;7:887. https://doi.org/10.3389/fnhum.2013.00887.
Rains JC, Poceta JS. Headache and sleep disorders: review and clinical implications for headache management. Headache: J Head Face Pain. 2006;46(9):1344–63.
Spierings EL, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Headache: J Head Face Pain. 2001;41(6):554–8.
Schneider KJ, Iverson GL, Emery CA, McCrory P, Herring SA, Meeuwisse WH. The effects of rest and treatment following sport-related concussion: a systematic review of the literature. Br J Sports Med. 2013;47(5):304–7.
Comper P, Bisschop S, Carnide N, Tricco A. A systematic review of treatments for mild traumatic brain injury. Brain Inj. 2005;19(11):863–80.
Fridman L, Scolnik M, Macpherson A, Rothman L, Guttmann A, Grool AM, et al. Annual trends in follow-up visits for pediatric concussion in emergency departments and physicians’ offices. J Pediatr. 2018;192:184–88.
Lezak MD. Neuropsychological assessment. USA: Oxford University Press; 2004.
Croall ID, Cowie CJ, He J, Peel A, Wood J, Aribisala BS, et al. White matter correlates of cognitive dysfunction after mild traumatic brain injury. Neurology. 2014;83(6):494–501.
Kinnaman KA, Mannix RC, Comstock RD, Meehan WP 3rd. Management of pediatric patients with concussion by emergency medicine physicians. Pediatr Emerg Care. 2014;30(7):458–61.
Collins M, Lovell MR, Iverson GL, Ide T, Maroon J. Examining concussion rates and return to play in high school football players wearing newer helmet technology: a three-year prospective cohort study. Neurosurgery. 2006;58(2):275–86. discussion 275-86
Cole WR, Arrieux JP, Schwab K, Ivins BJ, Qashu FM, Lewis SC. Test-retest reliability of four computerized neurocognitive assessment tools in an active duty military population. Arch Clin Neuropsychol: Off J Natl Acad of Neuropsychol. 2013;28:732–42.
Gualtieri CT, Johnson LG. Reliability and validity of a computerized neurocognitive test battery, CNS vital signs. Arch Clin Neuropsychol. 2006;21(7):623–43.
Schatz P, Sandel N. Sensitivity and specificity of the online version of ImPACT in high school and collegiate athletes. Am J Sports Med. 2013;41(2):321–26.
Sandel NK, Lovell MR, Kegel NE, Collins MW, Kontos AP. The relationship of symptoms and neurocognitive performance to perceived recovery from sports-related concussion among adolescent athletes. Appl Neuropsychol: Child. 2013;2(1):64–9.
Fazio VC, Lovell MR, Pardini JE, Collins MW. The relation between post concussion symptoms and neurocognitive performance in concussed athletes. NeuroRehabilitation. 2007;22(3):207–16.
Van Kampen DA, Lovell MR, Pardini JE, Collins MW, Fu FH. The “value added” of neurocognitive testing after sports-related concussion. Am J Sports Med. 2006;34(10):1630–5.
Mittenberg W, DiGiulio DV, Perrin S, Bass AE. Symptoms following mild head injury: expectation as aetiology. J Neurol Neurosurg Psychiatry. 1992;55(3):200–4.
Stulemeijer M, Andriessen TM, Brauer JM, Vos PE, Van Der Werf S. Cognitive performance after mild traumatic brain injury: the impact of poor effort on test results and its relation to distress, personality and litigation. Brain Inj. 2007;21(3):309–18.
Meehan WP, Mannix R, Monuteaux MC, Stein CJ, Bachur RG. Early symptom burden predicts recovery after sport-related concussion. Neurology. 2014;83(24):2204–10.
Alsalaheen BA, Whitney SL, Mucha A, Morris LO, Furman JM, Sparto PJ. Exercise prescription patterns in patients treated with vestibular rehabilitation after concussion. Physiother Res Int. 2013;18(2):100–8.
Goldberg JM. The vestibular system: a sixth sense. USA: OUP; 2012.
Hoffer ME, Gottshall KR, Moore R, Balough BJ, Wester D. Characterizing and treating dizziness after mild head trauma. Otol Neurotol. 2004;25(2):135–8.
Guskiewicz KM. Balance assessment in the management of sport-related concussion. Clin Sports Med. 2011;30(1):89–102.
Guskiewicz KM, Ross SE, Marshall SW. Postural stability and neuropsychological deficits after concussion in collegiate athletes. J Athl Train. 2001;36(3):263–73.
Storey EP, Master SR, Lockyer JE, Podolak OE, Grady MF, Master CL. Near point of convergence after concussion in children. Optom Vis Sci. 2017;94(1):96–100.
Kontos AP, Elbin RJ, Schatz P, Covassin T, Henry L, Pardini J, et al. A revised factor structure for the post-concussion symptom scale: baseline and postconcussion factors. Am J Sports Med. 2012;40(10):2375–84.
Society H. C. C. O. T. I. H. The international classification of headache disorders. Cephalalgia. 2013.
Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ. 1995;311(7004):541–4.
Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257–63.
Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache: J Head Face Pain. 2004;44(9):885–90.
Bailes J. Neuroprotection for the warrior: dietary supplementation with omega-3 fatty acids. Mil Med. 2011;176(10):1120.
Snow V, Weiss K, Wall EM, Mottur-Pilson C. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002;137(10):840–9.
Leddy JJ, Sandhu H, Sodhi V, Baker JG, Willer B. Rehabilitation of concussion and post-concussion syndrome. Sports Health. 2012;4(2):147–54.
Staab JP, Ruckenstein MJ, Solomon D, Shepard NT. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch Otolaryngol Head Neck Surg. 2002;128(5):554–60.
Ciuffreda KJ, Kapoor N, Rutner D, Suchoff IB, Han ME, Craig S. Occurrence of oculomotor dysfunctions in acquired brain injury: a retrospective analysis. Optom J Am Optom Assoc. 2007;78(4):155–61.
Capó-Aponte JE, Urosevich TG, Temme LA, Tarbett AK, Sanghera NK. Visual dysfunctions and symptoms during the subacute stage of blast-induced mild traumatic brain injury. Mil Med. 2012;177(7):804–13.
Cockerham GC, Weichel ED, Orcutt JC, Rizzo JF, Bower KS. Eye and visual function in traumatic brain injury. J Rehabil Res Dev. 2009;46(6):811–8.
Galetta KM, Brandes LE, Maki K, Dziemianowicz MS, Laudano E, Allen M, et al. The King–Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohort. J Neurol Sci. 2011;309(1):34–9.
King D, Brughelli M, Hume P, Gissane C. Concussions in amateur rugby union identified with the use of a rapid visual screening tool. J Neurol Sci. 2013;326(1–2):59–63.
Tjarks BJ, Dorman JC, Valentine VD, Munce TA, Thompson PA, Kindt SL, et al. Comparison and utility of King-Devick and ImPACT(R) composite scores in adolescent concussion patients. J Neurol Sci. 2013;334(1–2):148–53.
Sady MD, Vaughan CG, Gioia GA. School and the concussed youth: recommendations for concussion education and management. Phys Med Rehabil Clin N Am. 2011;22(4):701–19. ix
Thiagarajan P, Ciuffreda KJ, Capo-Aponte JE, Ludlam DP, Kapoor N. Oculomotor neurorehabilitation for reading in mild traumatic brain injury (mTBI): an integrative approach. NeuroRehabilitation. 2014;34(1):129–46.
Chen J-K, Johnston KM, Petrides M, Ptito A. Neural substrates of symptoms of depression following concussion in male athletes with persisting postconcussion symptoms. Arch Gen Psychiatry. 2008;65(1):81–9.
Smyth K, Sandhu SS, Crawford S, Dewey D, Parboosingh J, Barlow KM. The role of serotonin receptor alleles and environmental stressors in the development of post-concussive symptoms after pediatric mild traumatic brain injury. Dev Med Child Neurol. 2014;56(1):73–7.
Jensen MP, Turner JA, Romano JM. Changes in beliefs, catastrophizing, and coping are associated with improvement in multidisciplinary pain treatment. J Consult Clin Psychol. 2001;69(4):655–62.
Woodrome SE, Yeates KO, Taylor HG, Rusin J, Bangert B, Dietrich A, et al. Coping strategies as a predictor of post-concussive symptoms in children with mild traumatic brain injury versus mild orthopedic injury. J Int Neuropsychol Soc. 2011;17(02):317–26.
Roesch SC, Weiner BA. Meta-analytic review of coping with illness: do causal attributions matter? J Psychosom Res. 2001;50(4):205–19.
Carroll LJ, Cassidy JD, Côté P. The role of pain coping strategies in prognosis after whiplash injury: passive coping predicts slowed recovery. Pain. 2006;124(1):18–26.
Sandel N, Reynolds E, Cohen PE, Gillie BL, Kontos AP. Anxiety and mood clinical profile following sport-related concussion: from risk factors to treatment. Sport Exerc Perform Psychol. 2017;6(3):304–23.
Cooper DB, Bunner AE, Kennedy JE, Balldin V, Tate DF, Eapen BC, et al. Treatment of persistent post-concussive symptoms after mild traumatic brain injury: a systematic review of cognitive rehabilitation and behavioral health interventions in military service members and veterans. Brain Imaging Behav. 2015;9(3):403–20.
Hopko DR, Lejuez CW, Hopko SD. Behavioral activation as an intervention for coexistent depressive and anxiety symptoms. Clin Case Stud. 2004;3(1):37–48.
Mazzucchelli T, Kane R, Rees C. Behavioral activation treatments for depression in adults: a meta-analysis and review. Clin Psychol Sci Pract. 2009;16(4):383–411.
Mittenberg W, Canyock EM, Condit D, Patton C. Treatment of post-concussion syndrome following mild head injury. J Clin Exp Neuropsychol. 2001;23(6):829–36.
Hsieh M-Y, Ponsford J, Wong D, Schönberger M, Taffe J, Mckay A. Motivational interviewing and cognitive behaviour therapy for anxiety following traumatic brain injury: a pilot randomised controlled trial. Neuropsychol Rehabil. 2012;22(4):585–608.
Ponsford J, Lee N, Wong D, McKay A, Haines K, Alway Y, et al. Efficacy of motivational interviewing and cognitive behavioral therapy for anxiety and depression symptoms following traumatic brain injury. Psychol Med. 2016;46(5):1079–90.
Jorge RE, Acion L, Burin DI, Robinson RG. Sertraline for preventing mood disorders following traumatic brain injury: a randomized clinical trial. JAMA Psychiatry. 2016;73(10):1041–7.
Fann JR, Uomoto JM, Katon WJ. Sertraline in the treatment of major depression following mild traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2000;12(2):226–32.
Reddy CC, Collins M, Lovell M, Kontos AP. Efficacy of amantadine treatment on symptoms and neurocognitive performance among adolescents following sports-related concussion. J Head Trauma Rehabil. 2013;28(4):260–65.
Buckley TA, Munkasy BA, Clouse BP. Acute cognitive and physical rest may not improve concussion recovery time. J Head Trauma Rehabil. 2016;31(4):233.
Silverberg ND, Iverson GL, McCrea M, Apps JN, Hammeke TA, Thomas DG. Activity-related symptom exacerbations after pediatric concussion. JAMA Pediatr. 2016;170(10):946–53.
Abramowitz JS, Deacon BJ, Whiteside SP. Exposure therapy for anxiety: principles and practice. New York: Guilford Press; 2012.
Barlow D. Behavioral activation for depression. Clinical Handbook of Psychological Disorders. 4th ed. New York: The Guilford Press; 2008. p. 328–64.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Natalie Sandel has no conflicts of interest to declare. Michael Collins is the Co-Developer and Shareholder of ImPACT Applications, Inc.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Traumatic Brain Injury
Rights and permissions
About this article
Cite this article
Sandel, N., Collins, M.W. Diagnosis and Management of Mild Traumatic Brain Injury. Curr Trauma Rep 4, 127–137 (2018). https://doi.org/10.1007/s40719-018-0120-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40719-018-0120-8